Outcome of inoperable hepatocellular carcinoma patients receiving transarterial chemoembolisation: A real-life retrospective analysis in a Hong Kong regional hospital

Hong Kong Medical Journal

Volumn 15, Issue 5, 2009, Pages 339-345

  Yip, W M ^a   Hung, H G ^a   Lok, K H ^a   Li, K F ^a   Li, K K ^a   Szeto, M L ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Carcinoma, hepatocellular; Chemoembolization, therapeutic; Liver neoplasms; Prognosis; Survival rate

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; GELFOAM; IODINATED POPPYSEED OIL;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CAUSE OF DEATH; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; EMULSION; FEMALE; HEPATIC ARTERY; HONG KONG; HUMAN; LABORATORY TEST; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; GELATIN SPONGE, ABSORBABLE; HONG KONG; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70350212967     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hospital Authority, Hong Kong SAR Government. Hong Kong Cancer Registry; 2006.
2. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004;127(5 Suppl 1):179S-188S.
3. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430
4. Yeung YP, Lo CM, Liu CL, Wong BC, Fan ST, Wong J. Natural history of untreated nonsurgical hepatocellular carcinoma. Am J Gastroenterol 2005;100:1995-2004. (Pubitemid 43919392)
5. Lin DY, Lin SM, Liaw YF. Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:319S-328S.
6. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-338 (Pubitemid 29488775)
7. Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998;129:643-653 (Pubitemid 28480821)
8. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-1171 (Pubitemid 34454013)
9. Llovet JM, Real MI, Montaña X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-1739 (Pubitemid 34607087)
10. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-442 (Pubitemid 36152543)
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1968;53:457-481
12. Cox DR. Regression models and life-tables. J Roy Stat Soc 1972;34:187-220.
13. Greten TF, Papendorf F, Bleck JS, et al. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer 2005;92:1862-1868 (Pubitemid 40826134)
14. Ikeda M, Okada S, Yamamoto S, et al. Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Jpn J Clin Oncol 2002;32:455-460 (Pubitemid 43102766)
15. El Khaddari S, Gaudin JL, Abidi H, Picaud G, Rode A, Souquet JC. Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session [in French]. Gastroenterol Clin Biol 2002;26:728-734
16. Yuen MF, Chan AO, Wong BC, et al. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. Am J Gastroenterol 2003;98:1181-1185
17. Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 2000;73:109-114 (Pubitemid 30123735)
18. Ngan H, Lai CL, Fan ST, Lai EC, Yuen WK, Tso WK. Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam. Clin Radiol 1993;47:315-320 (Pubitemid 23152716)
19. Indicators of Poverty - An update for 2005 (paper 14/2006). HKSAR Commission on Poverty website: www.cop.gov.hk. Accessed 4 Apr 2009.
20. Hatanaka Y, Yamashita Y, Takahashi M, et al. Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology 1995;195:747-752
21. Cammà C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002;224:47-54. (Pubitemid 34680374)
22. Ernst O, Sergent G, Mizrahi D, Delemazure O, Paris JC, L'Herminé C. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. AJR Am J Roentgenol 1999;172:59-64. (Pubitemid 29028431)
23. Matsui O, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Demachi H. Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate. Cancer Chemother Pharmacol 1994;33 Suppl:84S-88S. (Pubitemid 24147972)
24. Huang YH, Wu JC, Chen SC, et al. Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter. Aliment Pharmacol Ther 2006;23:129-135 (Pubitemid 43381176)
25. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000;31:330-335
26. Chan AO, Yuen MF, Hui CK, Tso WK, Lai CL. A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 2002;94:1747-1752 (Pubitemid 34241113)